* Beauty Health Co SKIN.OQ SKIN.O is expected to show a
rise
in quarterly revenue when it reports results on May 10.
* The Long Beach California-based company is expected to
report
a 19.8% increase in revenue to $90.369 million from $75.42
million a year ago, according to the mean estimate from 10
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Beauty Health Co is
for a
loss of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Beauty
Health Co
is $17, above its last closing price of $10.49.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.04 0.04 0.05 Beat 32.4
Sep. 30 2022 0.02 0.02 0.05 Beat 164.7
Jun. 30 2022 -0.01 0.00 0.01 Beat 1,000.
9
Mar. 31 2022 -0.01 0.00 0.22 Beat 5,600
Dec. -0.02 -0.02 -0.12 Missed -535.3
31 2021
Sep. 30 2021 -0.02 -0.01 -1.63 Missed -11,75
4.5
Jun. 30 2021 0.00 0.00 0.09 Beat 5,489.
2
Mar. 31 2021 -0.02 -0.02 -0.06 Missed -140
This summary was machine generated May 8 at 18:33 GMT. All
figures in US dollars unless otherwise stated